More on ERAS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (7.7 Score)

Upcoming Events

- Earnings (11/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Erasca, Inc (NQ:ERAS)
Delayed: 16.03 +0.33 (2.10%)
Prev. Close $15.70  
Open$15.37 
52 Wk High$ 
52 Wk Low$ 
Day High$17.25 
Day Low$15.37 
P/E N/A  
EPS$ 
Volume8,245,940 

Friends, Peers and Foes (?): PODD, PSIX, HUBG, PRCT, NEHC (more...)

Sep 10, 2026 08:22 AM Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Erasca, Inc. (NASDAQ: ERAS); Hub Group, Inc. (NASDAQ: HUBG); and New Era Energy & Digital, Inc. (NASDAQ: NUAI): Grabar L
Sep 10, 2026 08:00 AM Erasca Announces Multiple Presentations at the Upcoming 38th EORTC-NCI-AACR Symposium
Sep 8, 2026 10:18 AM Important Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Hub Group, Inc. (NASDAQ: HUBG); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: SM
Sep 3, 2026 08:48 AM Attention Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Hub Group, Inc. (NASDAQ: HUBG); Hyliion Holdings Corp. (NYSE: HYLN); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Off
Aug 27, 2026 08:30 AM Erasca Inc (ERAS) PT Raised to $33 at JPMorgan
Aug 26, 2026 08:03 AM Important Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); New Era Energy & Digital, Inc. (NASDAQ: NUAI) (formerly known as New Era Helium (NASDAQ:
Aug 24, 2026 08:15 AM Form 8-K Erasca, Inc. For: Aug 24
Aug 24, 2026 08:01 AM FDA grants fast track status to Erasca's ERAS-0015 for pancreatic cancer
Aug 24, 2026 08:00 AM Erasca Granted FDA Fast Track Designation for Pan-RAS Molecular Glue ERAS-0015 in Patients with Metastatic Pancreatic Adenocarcinoma
Aug 17, 2026 02:14 PM Form 144 Erasca, Inc. Filed by: Erasca Foundation
View All Articles

Entities mentioned with ERAS

View All Entities